Envoy Medical, Inc. (NASDAQ:COCH) Short Interest Update

Envoy Medical, Inc. (NASDAQ:COCH) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 44,400 shares, a growth of 300.0% from the February 29th total of 11,100 shares. Currently, 0.7% of the company’s stock are sold short. Based on an average daily trading volume, of 400,100 shares, the days-to-cover ratio is presently 0.1 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Envoy Medical stock. Weiss Asset Management LP bought a new position in shares of Envoy Medical, Inc. (NASDAQ:COCH) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 20,000 shares of the company’s stock, valued at approximately $37,000. Weiss Asset Management LP owned approximately 0.10% of Envoy Medical as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 8.59% of the company’s stock.

Analyst Ratings Changes

Separately, Northland Securities initiated coverage on shares of Envoy Medical in a research note on Thursday, December 21st. They set an “outperform” rating on the stock.

Envoy Medical Price Performance

Shares of Envoy Medical stock traded up $0.01 on Friday, hitting $3.92. The company had a trading volume of 80,255 shares, compared to its average volume of 1,092,788. The business has a 50-day simple moving average of $3.22. Envoy Medical has a 52 week low of $0.75 and a 52 week high of $11.72.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.